A Leentvaar-Kuypers

1.1k total citations · 1 hit paper
8 papers, 896 citations indexed

About

A Leentvaar-Kuypers is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, A Leentvaar-Kuypers has authored 8 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in A Leentvaar-Kuypers's work include Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). A Leentvaar-Kuypers is often cited by papers focused on Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). A Leentvaar-Kuypers collaborates with scholars based in Netherlands, United States and Switzerland. A Leentvaar-Kuypers's co-authors include W. P. Schaasberg, H. W. Reesink, C.L. van der Poel, P.N. Lelie, P.J. van Exel‐Oehlers, Michael Houghton, S. Quan, H.T.M. Cuypers, A. Polito and I.N. Winkel and has published in prestigious journals such as The Lancet, American Journal of Public Health and Vaccine.

In The Last Decade

A Leentvaar-Kuypers

8 papers receiving 845 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay

1991 425 citations C.L. van der Poel, H. W. Reesink et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A Leentvaar-Kuypers Netherlands	6	796	742	112	101	58	8	896
Nicole Simon France	10	440 0.6×	406 0.5×	55 0.5×	106 1.0×	26 0.4×	12	577
H. W. Reesink Netherlands	13	649 0.8×	742 1.0×	63 0.6×	182 1.8×	40 0.7×	23	1.0k
J. Micallef Australia	8	877 1.1×	814 1.1×	28 0.3×	99 1.0×	60 1.0×	14	961
Vincenzo Guadagnino Italy	15	822 1.0×	752 1.0×	28 0.3×	104 1.0×	70 1.2×	42	950
J. Camps Spain	8	539 0.7×	485 0.7×	31 0.3×	78 0.8×	115 2.0×	20	663
Masaaki Mizui Japan	14	630 0.8×	699 0.9×	19 0.2×	68 0.7×	35 0.6×	23	828
Martí Vall Spain	9	547 0.7×	578 0.8×	21 0.2×	114 1.1×	19 0.3×	17	831
David Ipe United States	11	437 0.5×	959 1.3×	20 0.2×	258 2.6×	57 1.0×	19	1.2k
Barbara McGovern United States	5	1.0k 1.3×	831 1.1×	70 0.6×	385 3.8×	49 0.8×	7	1.4k
Zelma Buskell‐Bales United States	8	1.1k 1.4×	1.1k 1.5×	12 0.1×	84 0.8×	42 0.7×	8	1.3k

Countries citing papers authored by A Leentvaar-Kuypers

Since Specialization

Citations

This map shows the geographic impact of A Leentvaar-Kuypers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Leentvaar-Kuypers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Leentvaar-Kuypers more than expected).

Fields of papers citing papers by A Leentvaar-Kuypers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Leentvaar-Kuypers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Leentvaar-Kuypers. The network helps show where A Leentvaar-Kuypers may publish in the future.

Co-authorship network of co-authors of A Leentvaar-Kuypers

This figure shows the co-authorship network connecting the top 25 collaborators of A Leentvaar-Kuypers. A scholar is included among the top collaborators of A Leentvaar-Kuypers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Leentvaar-Kuypers. A Leentvaar-Kuypers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Thoelen, S, Pierre Van Damme, A Leentvaar-Kuypers, et al.. (1999). The first combined vaccine against hepatitis A and B: an overview. Vaccine. 17(13-14). 1657–1662. 105 indexed citations

2.

Leentvaar-Kuypers, A, et al.. (1994). [An outbreak of methicillin-resistant Staph aureus in a nursing home].. PubMed. 138(31). 1565–7. 1 indexed citations

3.

Bindels, Patrick, et al.. (1992). [Notification of current and former sexual partners of persons infected with HIV: is the time ripe for that?].. PubMed. 136(19). 933–7. 1 indexed citations

4.

Poel, C.L. van der, Dorine Bresters, H. W. Reesink, et al.. (1992). Early Antihepatitis C Virus Response with Second—Generation C200/C22 ELISA. Vox Sanguinis. 62(4). 208–212. 49 indexed citations

5.

Poel, C.L. van der, H. W. Reesink, H.T.M. Cuypers, et al.. (1991). Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. The Lancet. 337(8737). 317–319. 425 indexed citations breakdown →

6.

Haastrecht, H J van, et al.. (1991). The course of the HIV epidemic among intravenous drug users in Amsterdam, The Netherlands.. American Journal of Public Health. 81(1). 59–62. 50 indexed citations

7.

Poel, C.L. van der, H. W. Reesink, E. P. Mauser‐Bunschoten, et al.. (1991). Prevalence of Anti‐HCV Antibodies Confirmed by Recombinant Immunoblot in Different Population Subsets in The Netherlands. Vox Sanguinis. 61(1). 30–36. 33 indexed citations

8.

Poel, C.L. van der, H. W. Reesink, W. P. Schaasberg, et al.. (1990). Infectivity of blood seropositive for hepatitis C virus antibodies. The Lancet. 335(8689). 558–560. 232 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact